Page last updated: 2024-11-05

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Carcinoma, Anaplastic

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Carcinoma, Anaplastic in 1 studies

N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yu, Z2
Chen, Z1
Yang, L1
Ma, M1
Lu, S1
Wang, C1
Teng, C1
Nie, Y1

Other Studies

1 other study available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Carcinoma, Anaplastic

ArticleYear
Zinc chelator TPEN induces pancreatic cancer cell death through causing oxidative stress and inhibiting cell autophagy.
    Journal of cellular physiology, 2019, Volume: 234, Issue:11

    Topics: Antineoplastic Agents; Autophagy; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ch

2019